Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 06, 2020

SELL
$7.95 - $18.81 $15,900 - $37,620
-2,000 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$14.75 - $20.87 $14,750 - $20,870
-1,000 Reduced 33.33%
2,000 $30,000
Q4 2018

Feb 12, 2019

BUY
$10.6 - $17.49 $5,300 - $8,745
500 Added 20.0%
3,000 $42,000
Q3 2018

Nov 13, 2018

SELL
$16.65 - $21.85 $16,650 - $21,850
-1,000 Reduced 28.57%
2,500 $44,000
Q4 2017

Jan 31, 2018

SELL
$13.5 - $16.65 $20,250 - $24,974
-1,500 Reduced 30.0%
3,500 $54,000
Q3 2017

Oct 18, 2017

BUY
$6.05 - $14.95 $30,250 - $74,750
5,000
5,000 $75,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $668M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.